8-K: DIH Holding US, Inc. Announces Strong Second Quarter Results and Restates Prior Financials

DIH Holding US, Inc. reported a 39% revenue increase for the second quarter of 2025 and announced a restatement of its first quarter 2025 financials due to revenue recognition errors.

Summary

• DIH Holding US, Inc. announced its financial results for the second fiscal quarter ended September 30, 2024, showing a significant revenue increase of 39% year-over-year, reaching $18.2 million.
• The company's device revenue grew by 49% to $15.0 million, while service revenue remained flat at $2.7 million compared to the same period last year.
• Revenue growth was particularly strong in Europe, the Middle East, and Africa (EMEA) with a 72% increase, and in the Americas with a 20% increase.
• The company's gross margin improved to 52.6%, an 11% increase over the prior year period, and income before taxes was $0.1 million, a $2.5 million improvement year-over-year.
• DIH also announced a restatement of its first quarter 2025 financials, adjusting revenue to $17.0 million, a 30% year-over-year growth rate, from the previously reported $16.2 million, a 24.1% year-over-year growth rate.
• The restatement was due to the incorrect timing of revenue and cost of sales recognition for two device sales that should have been recorded in the first quarter.
• The company has adjusted its full-year 2025 revenue guidance to a range of $60 million to $67 million, citing macro environmental conditions and other business factors.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive due to strong revenue growth and improved profitability, but tempered by the restatement of financials and reduced revenue guidance.

Positives

• The company experienced strong revenue growth in the second quarter, driven by increased device sales.
• Gross margins improved significantly, indicating better cost management and pricing strategies.
• The company achieved positive income before taxes for the quarter, a substantial improvement from the previous year.
• There was significant revenue growth in the EMEA and Americas regions.
• The company appointed a new Chief Operating Officer, Dietmar Dold.

Negatives

• The company had to restate its first quarter 2025 financial results due to errors in revenue recognition.
• The company revised its full-year 2025 revenue guidance downwards, citing macro environmental conditions and other business factors.
• Service revenue remained flat compared to the prior year period.
• The company experienced a decrease in sales in the APAC region.

Risks

• The restatement of prior financial statements may raise concerns about the company's internal controls.
• Macroeconomic conditions and other business factors could impact the company's ability to achieve its revised revenue guidance.
• The company's reliance on device sales makes it vulnerable to fluctuations in demand.
• The company has a history of losses and a significant accumulated deficit.

Future Outlook

The company has adjusted its full-year 2025 revenue guidance to a range of $60 million to $67 million, citing macro environmental conditions and other business factors. They will continue to prioritize operational efficiencies.

Management Comments

• Our financial results represent another consecutive quarter of strong revenue growth and operational performance across the income statement, said Jason Chen, Chairman and CEO of DIH.
• We are pleased to have delivered positive income before taxes for the quarter in addition to recognizing a significant inflection in our gross margin profile.
• While we will continue to prioritize operational efficiencies going forward, we are adjusting our revenue guidance for the remainder of 2025 to account for certain macro environmental conditions as well as other business factors.

Industry Context

The company operates in the growing market of rehabilitation robotics, which is driven by an aging population and increasing demand for advanced rehabilitation solutions. The company's focus on robotic devices and interactive visual stimulation aligns with current trends in the industry.

Comparison to Industry Standards

• While specific competitor data is not provided, DIH's 39% revenue growth in the second quarter is strong compared to the broader medical device industry, which typically sees single-digit growth rates.
• The 11% improvement in gross margin suggests that DIH is becoming more efficient in its operations, which is a positive sign compared to industry averages.
• Companies like Ekso Bionics and ReWalk Robotics are also involved in rehabilitation robotics, but DIH's focus on a broader range of devices and solutions may give it a competitive edge.
• The restatement of financials is a concern, as it indicates potential issues with internal controls, which is not ideal compared to industry best practices.

Management Changes

Stakeholder Impact

• Shareholders may be concerned about the restatement of financials but encouraged by the strong revenue growth.
• Employees may be impacted by the company's focus on operational efficiencies.
• Customers may benefit from the company's continued investment in research and development.
• Suppliers may see increased demand due to the company's growth.

Next Steps

• The company will file an amended 10Q-A for June 30, 2024 and the 10Q for September 30, 2024 no later than November 19, 2024.
• The company will continue to prioritize operational efficiencies.

Key Dates

Keywords

financial results, revenue, restatement, gross margin, device sales, rehabilitation, robotic devices, EMEA, Americas, guidance